ClinicalTrials.Veeva

Menu
I

Irmandade da Santa Casa de Misericordia de Sao Paulo | Hospital Central - Cardiology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pimodivir
Tenecteplase
LOXO-305
Milvexian
TAR-210

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 7 total trials

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS)

The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major advers...

Enrolling
Acute Coronary Syndrome
Drug: Milvexian
Other: Placebo

The main purpose of this study is to compare the disease-free survival between participants receiving treatment with TAR-210 versus investigator's ch...

Enrolling
Non-Muscle Invasive Bladder Cancer
Drug: Gemcitabine
Drug: MMC

This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib (LOXO-30...

Active, not recruiting
Lymphoma, Mantle-Cell
Drug: Ibrutinib
Drug: Pirtobrutinib

Trial sponsors

Janssen (J&J Innovative Medicine) logo
Loxo Oncology logo
U
H

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems